05.28.26 -- STREAM Edition: Get It Right With The Gemba

Delve into the intricacies of combination products and the regulatory expectations, including risk-based determination, evaluation, and documentation approaches for performance requirements.

Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.

See how packaging safeguards life science products and why innovation cultures matter. Oliver Stauffer offers grounded insights on turning scientific advances into sustainable, real-world impact.

The idea of the Gemba walk originated after World War II in Japan, specifically in relation to automotive production at Toyota. The word can be translated to “the real or actual place,” referring to where the work takes place—in the case of pharma or automobiles, on the factory floor.

In this segment from the Pharmaceutical Online Live event, our panelists talk about designing the production space to minimize interventions, involving operators in design, selecting the right technology, and considerations for ready to use components versus bulk components.

A robust formulation development approach integrates scientific principles, systematic formulation development, and preclinical models to facilitate early identification of candidates with poor developability.